Real-Time PMA Supplement Review
Expedited PMA supplement review pathway where FDA and the manufacturer meet to review minor device or labeling changes in real time.
Definition
Real-time PMA supplements are for eligible minor changes affecting safety or effectiveness, such as certain design, software, or labeling changes, for which limited review is appropriate and new clinical data are not needed. FDA determines suitability and uses interactive review. Approval is required before implementation unless another authorized provision applies. Manufacturing-method or process changes should be assessed for the 30-day notice route rather than presumed eligible for real-time review.What this means in practice
Real-time PMA supplements are for eligible minor changes affecting safety or effectiveness, such as certain design, software, or labeling changes, for which limited review is appropriate and new clinical data are not needed. FDA determines suitability and uses interactive review. Approval is required before implementation unless another authorized provision applies. Manufacturing-method or process changes should be assessed for the 30-day notice route rather than presumed eligible for real-time review.Examples
- Illustrative: A manufacturer utilized Real-Time Review to quickly gain approval for a minor software update that improved the user interface of their approved diagnostic device without altering its core functionality or clinical indications.
- Hypothetical: a manufacturer consults FDA about a minor design change supported by bench testing and no new clinical data before requesting real-time supplement review.
- Illustrative: After an eligible-determination request, a company successfully obtained approval for a minor labeling revision through a Real-Time Review meeting, which clarified instructions for use without changing clinical claims.
- •Requesting Real-Time Review for changes that aren't truly minor, FDA will reject the request and the sponsor loses time.
- •Failing to prepare materials at PMA-supplement quality for the meeting, Real-Time Review compresses calendar time, not depth of evidence.
- •Do not confuse real-time review with a Special PMA Supplement, Changes Being Effected, or with a 30-day manufacturing notice.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsPMA submission strategy where a manufacturer submits portions of the PMA (modules) sequentially as they become ready, rather than as a single complete application.
FDA submission mechanisms for changes to PMA-approved devices, selected according to the change and evidence required.
FDA's most stringent device marketing application, required for high-risk Class III devices.
Yearly report required for Class III PMA devices summarizing changes, complaints, and post-approval study status.
More in Regulatory
· Same categoryFDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.
Where this term appears across MedTech Terms.
Sources
4 sourcesSources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
Official-source claim check:
Real-time supplements address minor changes affecting safety or effectiveness when limited review is appropriate, generally without new clinical data.
Partial review: verified corrections are applied, but this is not a full accuracy certification. The last full review date is unchanged.
Remaining verification limits
- Original merged record reviewed in full. Illustrative examples are hypothetical, not verified case histories. Evidence supports the specific propositions below, not an assertion that every linked page verifies all merged content.
- 1Real-Time PMA Supplements GuidanceTier 2 UncheckedFDAfda.gov
- 2IMDRF DocumentsTier 2 VerifiedIMDRFimdrf.org
- 3RAPS Regulatory FocusTier 4 VerifiedRAPSraps.org
- 4FDA supplement decision guidanceTier 2 UncheckedFDAfda.gov
Inline markers like [1] jump to the matching reference above.